Invention Grant
- Patent Title: Fused quadracyclic compounds, compositions and uses thereof
-
Application No.: US16039877Application Date: 2018-07-19
-
Publication No.: US10562909B2Publication Date: 2020-02-18
- Inventor: Casey C. McComas , Michael H. Serrano-Wu , Joseph P. Vacca
- Applicant: Tabomedex Biosciences, LLC
- Applicant Address: US MA Boxford
- Assignee: Tabomedex Biosciences, LLC
- Current Assignee: Tabomedex Biosciences, LLC
- Current Assignee Address: US MA Boxford
- Agency: Foley Hoag LLP
- Main IPC: A61K31/551
- IPC: A61K31/551 ; A61K31/5517 ; C07D471/22 ; C07D487/14 ; C07D487/22 ; C07D519/00 ; A61K45/06
Abstract:
Provided herein are substituted fused quadracyclic compounds useful as inhibitors of MK2. The invention further provides pharmaceutical compositions of the compounds of the invention. The invention also provides medical uses of substituted fused quadracyclic compounds.
Public/Granted literature
- US20180319809A1 FUSED QUADRACYCLIC COMPOUNDS, COMPOSITIONS AND USES THEREOF Public/Granted day:2018-11-08
Information query
